Clinics in Dermatology
Volume 24, Issue 3 , Pages 201-212 , May 2006

Fungal infections

  • Roderick J. Hay, MD, FRCP

      Affiliations

    • Corresponding Author InformationTel.: +44 289 027 2186; fax: +44 289 032 0809.

References 

  1. Kibbler CC, MacKenzie DWR, Odds FC. Principles and Practice of Clinical Mycology. Chichester: Wiley; 1996;
  2. Kane J, Krajden S, Summerbell RC, et al. Infections caused by Trichophyton raubitschekii: clinical and epidemiological features. Mycoses. 1990;33:499–506
  3. Hay RJ, Reid S, Talwat E, et al. Endemic tinea imbricata: a study on Goodenough Island, PNG. Trans R Soc Trop Med. 1984;78:246–251
  4. Ghannoum M, Isham N, Hajjeh R, et al. Tinea capitis in Cleveland: survey of elementary school students. J Am Acad Dermatol. 2003;48:189–193
  5. Hay RJ, Moore MK. Clinical features of superficial fungal infections caused by Hendersonula toruloidea and Scytalidium hyalinum. Br J Dermatol. 1984;110:677–683
  6. Crespo Erchiga V, Delgado Florencio V. Malassezia species in skin diseases. Curr Opin Infect Dis. 2002;15:133–142
  7. Winn RE. A contemporary view of sporotrichosis. Curr Top Med Mycol. 1995;6:73
  8. Lyon GM, Zurita S, Casquero J, et al. Population-based surveillance and a case-control study of risk factors for endemic lymphocutaneous sporotrichosis in Peru. Clin Infect Dis. 2003;36:34–39
  9. de Lima Barros MB, de Oliveira Schubach A, Galhardo MC, et al. Sporotrichosis with widespread cutaneous lesions: report of 24 cases related to transmission by domestic cats in Rio de Janeiro, Brazil. Int J Dermatol. 2003;42:677–681
  10. Carvalho MT, de Castro AP, Baby C, et al. Disseminated cutaneous sporotrichosis in a patient with AIDS: report of a case. Revista Da Sociedade Brasileira de Medicina Tropical. 2002;35:655–659
  11. Hu S, Chung WH, Hung SI, et al. Detection of Sporothrix schenckii in clinical samples by a nested PCR assay. J Clin Microbiol. 2001;41:1414–1418
  12. Sandhu K, Gupta S. Potassium iodide remains the most effective therapy for cutaneous sporotrichosis. J Derm Treat. 2003;14:200–202
  13. Kauffman CA, Hajjeh R, Chapman SW. Practice guidelines for the management of patients with sporotrichosis. For the Mycoses Study Group. Infectious Diseases Society of America. Clin Infect Dis. 2000;30:684–687
  14. Hay RJ, Mahgoub ES, Leon G, et al. Mycetoma. J Med Vet Mycol. 1992;30(Suppl 1):41–46
  15. Fahal AH. Mycetoma: a thorn in the flesh. Trans R Soc Trop Med Hyg. 2004;98:3–11
  16. Ahmed A, van de Sande W, Verbrugh H, et al. Madurella mycetomatis strains from mycetoma lesions in Sudanese patients are clonal. J Clin Microbiol. 2003;41:4537–4541
  17. Khatri ML, Al-Halali HM, Fouad Khalid M, et al. Mycetoma in Yemen: clinicoepidemiologic and histopathologic study. Int J Dermatol. 2002;49:586–593
  18. Abd El Bagi ME. New radiographic classification of bone involvement in pedal mycetoma. AJR Am J Roentgenol. 2003;180:665–668
  19. Sarris I, Berendt AR, Athanasous N, et al. MRI of mycetoma of the foot: two cases demonstrating the dot-in-circle sign. Skeletal Radiol. 2003;32:179–183
  20. Yera H, Bougnoux ME, Jeanrot C, et al. Mycetoma of the foot caused by Fusarium solani: identification of the etiologic agent by DNA sequencing. J Clin Microbiol. 2003;41:1805–1808
  21. Welsh O, Salinas MC, Rodriguez MA. Treatment of eumycetoma and actinomycetoma. Curr Top Med Mycol. 1995;6:47–51
  22. Lacroix C, de Kerviler E, Morel P, et al. Madurella mycetomatis mycetoma treated successfully with oral voriconazole. Br J Dermatol. 2005;152:1067–1068
  23. Restrepo A. Treatment of tropical mycoses. J Am Acad Dermatol. 1994;31:S91–S94
  24. Esterre P. Treatment of chromomycosis with terbinafine: preliminary results of an open pilot study. Br J Dermatol. 1996;134(Suppl 46):33–36
  25. Esterre P, Risteli L, Ricard-Blum S. Immunohistochemical study of type I collagen turn-over and of matrix metalloproteinases in chromoblastomycosis before and after treatment by terbinafine. Pathol Res Pract. 1998;194:653–847
  26. Silva JP, de Souza W, Rozental S. Chromoblastomycosis: a retrospective study of 325 cases in the Amazonic Region (Brazil). Mycopathologia. 1999;143:171–175
  27. Minotto R, Bernardi CD, Mallmann LF, et al. Chromoblastomycosis: a review of 100 cases in the state of Rio Grande do Sul, Brazil. J Am Acad Dermatol. 2001;44:585–592
  28. Esterre P, Pecarrere JL, Raharisolo C, et al. Squamous cell carcinoma arising from chromomycosis. Report of two cases. Ann Pathol. 1999;19:516–520
  29. Kumarasinghe SP, Kumarasinghe MP. Itraconazole pulse therapy in chromoblastomycosis. Eur J Dermatol. 2000;10:220–222
  30. Perez A. Terbinafine, broad new spectrum of indications in several subcutaneous and systemic and parasitic diseases. Mycoses. 1999;42 Suppl 2:111–114
  31. Matsumoto T, Ajello L, Matsuda T, et al. Developments in hyalohyphomycosis and phaeohyphomycosis. J Med Vet Mycol. 1994;32(Suppl 1):329–333
  32. Freimoser FM, Screen S, Hu G, et al. EST analysis of genes expressed by the zygomycete pathogen Conidiobolus coronatus during growth on insect cuticle. Microbiol. 2003;149:1893–1900
  33. Taborda PR, Taborda VA, McGinnis MR. Lacazia loboi gen. nov., comb. nov., the etiologic agent of lobomycosis. J Clin Microbiol. 1999;37:2031–2033
  34. Brun AM. Lobomycosis in three Venezuelan patients. Int J Dermatol. 2000;38:302–305
  35. Sorrell TC. Cryptococcus neoformans variety gattii. Med Mycol. 2001;39:155–168
  36. Sriburee P, Khayhan S, Khamwan C, et al. Serotype and PCR-fingerprints of clinical and environmental isolates of Cryptococcus neoformans in Chiang Mai Thailand. Mycopathologia. 2004;158:25–31
  37. Bellamy R, Sangeetha S, Paton NI. Causes of death among patients with HIV in Singapore from 1985 to 2001: results from the Singapore HIV Observational Cohort Study (SHOCS). HIV Med. 2004;5:289–295
  38. Khanna N, Chandramuki A, Desai A, et al. Cryptococcosis in the immunocompromised host with special reference to AIDS. Indian J Chest Dis Allied Sci. 2000;42:311–315
  39. Correa Mdo P, Severo LC, Oliveira Fde M, et al. The spectrum of computerized tomography (CT) findings in central nervous system (CNS) infection due to Cryptococcus neoformans var. gattii in immunocompetent children. Rev Inst Med Trop Sao Paulo. 2002;44:283–287
  40. Cano MV, Hajjeh RA. The epidemiology of histoplasmosis: a review. Semin Respir Infect. 2001;16:109–116
  41. Wheat J. Endemic mycoses in AIDS: a clinical review. Clin Microbiol Rev. 1995;8:149–155
  42. Muotoe-Okafor FA, Gugnani HC, Gugnani A. Skin and serum reactivity among humans to histoplasmin in the vicinity of a natural focus of Histoplasma capsulatum var. duboisii. Mycopathologia. 1996;34:71–74
  43. N'Golet A, N'Gouoni BG, Moukassa D, et al. Maxillary African histoplasmosis: unusual diagnostic problems of an unusual presentation. Pathol Res Pract. 2005;200:841–844
  44. Musoke F. Spinal African histoplasmosis simulating tuberculous spondylitis. African Health Sci. 2001;1:28–29
  45. Velho GC, Cabral JM, Massa A. African histoplasmosis: therapeutic efficacy of itraconazole. J Eur Acad Dermatol Venereol. 1998;10:77–80
  46. Bagagli E, Franco M, Bosco Sde M, et al. High frequency of Paracoccidioides brasiliensis infection in armadillos (Dasypus novemcinctus): an ecological study. Med Mycol. 2003;41:217–223
  47. Simoes LB, Marques SA, Bagagli E. Distribution of paracoccidioidomycosis: determination of ecologic correlates through spatial analyses. Med Mycol. 2004;42:517–523
  48. dos Santos WA, da Silva BM, Passos ED, et al. Association between smoking and paracoccidioidomycosis: a case-control study in the State of Espirito Santo, Brazil. Cad Saude Publica. 2003;19:245–253
  49. Godoy H, Reichart PA. Oral manifestations of paracoccidioidomycosis. Report of 21 cases from Argentina. Mycoses. 2003;46:412–417
  50. Silva-Vergara ML, Teixeira AC, Curi VG, et al. Paracoccidioidomycosis associated with human immunodeficiency virus infection. Report of 10 cases. Med Mycol. 2003;41:259–263
  51. Pellegrino A, de Capriles CH, Magaldi S, et al. Case report: severe juvenile type paracoccidioidomycosis with hepatitis C. Am J Trop Med Hyg. 2003;68:301–303
  52. Tobon AM, Agudelo CA, Osorio ML, et al. Residual pulmonary abnormalities in adult patients with chronic paracoccidioidomycosis: prolonged follow-up after itraconazole therapy. Clin Infect Dis. 2003;37:898–904
  53. Supparatpinyo K, Khamwan C, Baosoung V, et al. Disseminated Penicillium marneffei infection in Southeast Asia. Lancet. 1994;344:110–113
  54. Chariyalertsak S, Sirisanthana T, Supparatpinyo K, et al. Seasonal variation of disseminated Penicillium marneffei infections in northern Thailand: a clue to the reservoir?. J Infect Dis. 1996;173:1490–1495
  55. Youngchim S, Hay RJ, Hamilton AJ. Melanization of Penicillium marneffei in vitro and in vivo. Microbiology. 2005;151:291–299
  56. Ranjana KH, Priyokumar K, Singh TJ, et al. Disseminated Penicillium marneffei infection among HIV-infected patients in Manipur state, India. J Infect. 2002;45:268–271
  57. Huynh TX, Nguyen HC, Dinh Nguyen HM, et al. Penicillium marneffei infection and AIDS. A review of 12 cases reported in the Tropical Diseases Centre, Ho Chi Minh City (Vietnam) Sante. 2003;13:149-153.
  58. Desakorn V, Simpson AJ, Wuthiekanun V, et al. Development and evaluation of rapid urinary antigen detection tests for diagnosis of penicilliosis marneffei. J Clin Microbiol. 2002;40:3179–3183
  59. Tsunemi Y, Takahashi T, Tamaki T. Penicillium marneffei infection diagnosed by polymerase chain reaction from the skin specimen. J Am Acad Dermatol. 2003;49:344–346

PII: S0738-081X(05)00167-7

doi: 10.1016/j.clindermatol.2005.11.011

Clinics in Dermatology
Volume 24, Issue 3 , Pages 201-212 , May 2006

Article Tools

* Image Usage & Resolution